Valiant Laboratories Ltd Share Price (VALIANTLAB)

Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals through Deed of Partnership dated October 17 1980. The said Partnership Firm M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16 2021 issued by the Central Registration Centre Registrar of Companies.The Company is an Active Pharmaceutical Ingredient API / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually commenced manufacturing of Paracetamol by late 1982. Paracetamol Scientific name: Acetaminophen or parahydroxyacetanilide C8H9NO2 is one of the most commonly taken analgesic worldwide and is recommended as the firstline therapy in pain conditions by the World Health Organization WHO. Paracetamol has several applications such as usage in treatment of headaches muscle aches arthritis back aches toothaches cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form regular tablets effervescent tablets injection suppository and other forms. Paracetamol is often found combined with other drugs in many over the counter OTC allergy medications cold medications sleep medications pain relievers and other products. Presently the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area Boisar in the State of Maharashtra with an annual installed capacity of 9000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area Palghar Maharashtra the Company has an inhouse RD infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora Director and Dhanvallabh Ventures LLP DVL. In July 2022 the Company formed its wholly owned subsidiary Valiant Advanced Sciences Private Limited VASPL to diversify the business activities.The Company has come out with a Public Issue of issuing upto 11556000 Equity Shares through fresh issue..

Revenue: ₹46.82Cr as on June 2025 (Q1 FY26)
Net Profit: ₹1.82Cr as on June 2025 (Q1 FY26)
Listing date: 06 Oct, 2023
Chairperson Name: Velji Gogri